Research Article

Virological Breakthrough: A Risk Factor for Loss to Followup in a Large Community-Based Cohort on Antiretroviral Therapy

Table 2

Programmatic outcome of those who resuppressed compared to those who never experienced virological breakthrough.

Never had breakthrough ( 𝑛 = 2 1 0 9 )Breakthrough and resuppressed ( 𝑛 = 5 6 7 ) 𝑃 v a l u e

Lost to followup:
𝑛 (%)
235 (11)132 (23) 𝑃 = . 0 0 0 0 *
Died on treatment:
𝑛 (%)
64 (3.1)25 (4.4) 𝑃 = . 1 1 8 4 *
Transfer out: 𝑛 (%)186 (8.9)62 (11) 𝑃 = . 1 6 2 3 *
Continue in care:
𝑛 (%)
 (i) On first line1624 (77)302 (53) 𝑃 = . 0 0 0 0 *
 (ii) Failed first line0 (0)46 (8) 𝑃 = . 0 0 0 0 *

*Chi-squared (df = 1).